Blueprint Medicines (BPMC) Appoints Lynn Seely, MD to Board of Directors

biospace.com Apr 16 2016 BoardMoves

Blueprint Medicines Corporation, a leader in discovering and developing highly selective kinase medicines for patients with genomically defined diseases, today announced the appointment of Lynn Seely, M.D. to its board of directors ...

Read Full Article

Bookmark or Share this article

Login to comment.

Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
Boeing CFO Joins JPMorgan Board also mentions Board of directors
Alzheon Appoints Dennis H Langer MD JD To Board Of Directors also published in biospace.com
Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Blueprint Medicines (BPMC) Appoints Lynn Seely, MD to Board of Directors

Login to comment.

Related Articles

Topics Mentioned

Blueprint Medicines (BPMC) Appoints Lynn Seely, MD to Board of Directors

Login to comment.

Related Articles

Categories

BoardProspects Features:

Topics Mentioned